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Abstract
 This work is part of an ongoing study that investigates the upregulation of LTBP-1 in 
mammary epithelial cells as well as the differentiation of breast adipose stem cells (BASCs) in 
the presence of TGF-β1. Through immunofluorescence imaging, LTBP-1 is shown to co-lo-
calize with fibronectin fibrils in adipose stem cells. Previous work from our lab has shown that 
blocking fibronectin fibril formation can inhibit Epithelial-Mesenchymal Transition. Thus, 
targeting of fibronectin assembly could be a potent new therapeutic in cancer treatment. In 
the current work, we focus on the pharmacodynamics of a FN assembly inhibitor derived 
from the protein Adhesin F1 (refered to as FUD). FN Fibril area was quantified in samples 
with different FUD dosages to determine the optimal concentration. The optimal dosage for 
this inhibitor was obtained for both mammary epithelial cells and breast adipose stem cells 
through image processing. Additionally, toxicity studies were performed using MTT assays. 
Results suggest that in both the mammary epithelial cells and the breast adipose stem cells, 
there is a range of dosing for which FN fibril formation is blocked but toxicity is low.
Introduction
 This study investigates the correlation between the secretion of Latent Transforming 
Growth Factor Beta Binding Protein-1 (LTBP-1) and the occurrence of Epithelial to Mes-
enchymal Transition (EMT) in mammary epithelial cells (MCF10As). EMT is a process by 
which epithelial cells, which are the cells that line all of the organs within our body, change 
their phenotype and function to become mesenchymal cells, which are cells responsible for 
tissue growth and assembly throughout the body. This process has been implicated as an early 
step in cancer progression (1). Upon addition of certain growth factors, such as TGF-β1, epi-
thelial cells have been shown to transdifferentiate into mesenchymal cells.
 TGF-1 also causes the activation of breast adipose stem cells (BASCs). Experimental 
data indicate that BASCs can differentiate into cancer-associated fibroblast (CAF)-like cells 
under the influence of breast cancer-derived soluble factors (2). BASCs stimulate desmoplasia 
as well as breast cancer cell growth and invasion in vivo (3), making this resident stromal cell 
of particular interest.
 Previous research has demonstrated that adding TGF-β1 to mammary cells increases 
fibronectin secretion, which can serve as a growth factor delivery system by concentrating 
growth factors at domains III12-14. This research seeks to determine whether the addition 
of TGF-β1 causes an increase in latent TGF- β1 which then concentrates at the cell surface. 
We believe that upon the activation of LTBP-1, signal transduction and gene transcription 
associated with EMT is initiated, resulting in a positive feedback cycle. We hypothesize that 
the mechanism of EMT in epithelial cells involves a positive feedback loop by which increased 
TGF-β1 increases the expression/assembly of fibronectin, which then increases the secretion 
of LTBP-1, the inactive form of TGF-β1, initiating the process of EMT. In BASCs, we expect 
differentiation into a myofibroblast phenotype in the presence of this growth factor. Thus we 
targeted FN assembly inhibition in mammary cells through the functional upstream domain 
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of the bacterial cell wall protein adhesin F1, better known as FUD.
Methods
 To analyze the relationship between EMT growth factor signaling and fibronectin 
assembly, approximately 0.2×105 BASCs or 0.1×106 MCF10As were seeded on coverslips in 
the presence or absence of 2 ng/ml of TGF-β1 to determine whether the addition of TGF-β1 
increased the formation of fibronectin fibrils and the co-localization of LTBP-1. Additionally, 
the correlation between FUD dosage and fibril formation was also observed quantitatively 
and qualitatively in MCF10as and BASCs through immunofluorescence. MTT assays were 
conducted to analyze the effect of FUD concentration on cell death in both BASCs and MC-
F10as.
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Figure 1: The Effect of FUD Concentration on 
Fibril Formation. Immunofluoresence images of 
MCF10As. A) Control 0 nM FUD: Abundance of 
short fibrils; B) 50 nM FUD: Less fibril formation as 
compared to control; C) 125 nM FUD: FN assembly 
sufficiently inhibited; D) 500 nM FUD: No fibril 
formation; A1-D1) Representative sections of A-D; 
A2-D2) Representative images of total fibronectin 
fibril area.
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Figure 2: The Effect of Fibonectin Inhibitor FUD on Toxicity of MCF10As.  Figure 2: The Effect of Fibonectin Inhibitor FUD 
on Toxicity of MCF10As.
Figure 3: Dose Response and Toxicity of Fibronec-
tin Inhibitor on MCF10As. Percent fibronectin fi-
bril inhibition and percent toxicity as a function of 
inhibitor dose.
Figure 4:The Effect of FUD Concentration on 
Fibril Formation. Immunofluoresence images of 
bASCs. A) Control 0 nM FUD: Abundance of short 
fibrils; B) 125 nM FUD: Less fibril formation as 
compared to control; C) 500 nM FUD: Substandi-
ally decreased FN assembly D) 800 nM FUD: FN 
assembly sufficiently inhibited; E) 1500 nM FUD: 
No fibril formation; F) No fibril assembly; A1-F1) 
Representative sections of A-D; A2-F2) Representa-
tive images of total fibronectin fibril area.
Discussion
We have established a correlation between fibronectin assembly and LTBP-1 co-localization. 
We believe that a mechanism behind TGF-β1-induced EMT involves a positive feedback 
loop of which addition of TGF-β1 increases the secretion of LTBP-1, its co-localization, and 
its activation, causing the induction of EMT (Figure 1). Furthermore, fibronectin assembly 
on BASCs decreased with increasing FUD dosage. MTT results showed that there was no 
significant effect of FUD dosage on BASCs, however MCF10as are less tolerable to FUD as 
cell death started to occur at 500nM. These results indicate that LTBP-1 secretion is linked to 
TGF-β1 activation. In order to stop the cycle of EMT the optimal FUD dosage was obtained 
for BASCs as 600 nM and MCF10As as 125 nM.
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Figure 6: Dose Response and Toxicity of Fi-
bronectin Inhibitor on bAScs. Percent fibronectin 
fibril inhibition and percent toxicity as a function of 
inhibitor dose.
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Figure 5: The Effect of Fibonectin Inhibitor FUD on Toxicity of bASCs.  
Figure 5: The Effect of Fibonectin Inhibitor FUD 
on Toxicity of bASCs.
Figure 7: The Effect of FUD on Fibril Forma-
tion and localization of LTBP-1. Composite im-
munofluoresence images of MCF10As. Red channel: 
actin, green channel: LTBP-1 and white channel: fi-
bronectin. Addition of TGF-β1 causes an increase in 
fibronectin fibrillogenesis and corresponding LTBP-1 
secretion, which then becomes localized on fibronec-
tin fibrils. This increased secretion and colocalization 
of LTPB-1 is blocked when fibril formation is inhib-
ited.
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Figure 8: Schematic Representation of Hypothe-
sized Mechanism. Illustration of the specific mecha-
nism of EMT being studied.. The red boxes signify the 
hypothesized positive feedback loop that is inducing 
EMT.
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